The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer

The multidrug resistance proteins Pgp, MRP, and BCRP as markers for lowering the efficacy of tamoxifen in the treatment of breast cancer

The antiestrogen tamoxifen was examined for its effect on the interaction of monoclonal antibodies with the multidrug resistance markers: with Pgp and MRP1 in the cultured T-lymphoblast leukemia cell line Jurkat and with BCRP in the cultured cervical cancer cell line HeLa. The investigation used imm...

Full description

Saved in:
Bibliographic Details
Main Authors: T. A. Bogush, E. A. Dudko, E. A. Bogush, B. E. Polotsky, S. A. Tyulyandin, M. I. Davydov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Опухоли женской репродуктивной системы
Subjects:
tamoxifen
multidrug resistance proteins
pgp
mrp1
bcrp
breast cancer
predictive markers
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/136
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items